RCE 2.52% 58.0¢ recce pharmaceuticals ltd

Ann: Positive Sinusitis Patient Update - Special Access Scheme, page-80

  1. 5,260 Posts.
    lightbulb Created with Sketch. 680
    I wonder how they plan to price this product should it get to market. They have stated the ingredients are cheap and plentiful I believe. Will they price it as a "last resort" treatment that we know will work if all else fails and is kept in reserve. Or will they price it in such a way that it becomes the primary treatment for target infections like sinusitis etc. Maybe they plan different marketing plans for simpler things like burns and sinusitis but maybe sepsis will be more of a last resort. Just speculating and dreaming of the day we have products in the market. The recent SAS treatment of recurring sinusitis seems like an incredible step forward.
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
58.0¢
Change
-0.015(2.52%)
Mkt cap ! $120.3M
Open High Low Value Volume
59.5¢ 59.5¢ 58.0¢ $7.304K 12.40K

Buyers (Bids)

No. Vol. Price($)
1 37917 58.0¢
 

Sellers (Offers)

Price($) Vol. No.
59.0¢ 700 3
View Market Depth
Last trade - 13.28pm 05/06/2024 (20 minute delay) ?
Last
57.0¢
  Change
-0.015 ( 2.56 %)
Open High Low Volume
58.0¢ 58.0¢ 57.0¢ 33540
Last updated 13.49pm 05/06/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.